Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Corium, Inc. clinical trials
The registry lists 14 studies whose lead sponsor is Corium, Inc. or one of 1 company grouped under it. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 1, 2026.
Keep track of what changes. Save the Corium, Inc. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Corium, Inc..
- Corium, Inc.8 studiesSame company
Something wrong?
- 6 studies →
Studies
Recruiting first, then most recently updated. Showing 14 of 14.
- A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal SubjectsRecruitingNCT07794150Phase 1
Sponsor listed in the registry: Corium Innovations, Inc. · First submitted after Corium Innovations, Inc. left Corium, Inc.
- A Study to Assess the Bioavailability and Adhesion of Estradiol/Levonorgestrel TDS in Healthy Post-Menopausal Female ParticipantsActive, not recruitingNCT07851649Phase 1
Sponsor listed in the registry: Corium Innovations, Inc. · First submitted after Corium Innovations, Inc. left Corium, Inc.
- A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy SubjectsActive, not recruitingNCT07452692Phase 1
Sponsor listed in the registry: Corium Innovations, Inc. · First submitted after Corium Innovations, Inc. left Corium, Inc.
- A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy SubjectsCompletedNCT07571824Phase 1
Sponsor listed in the registry: Corium Innovations, Inc. · First submitted after Corium Innovations, Inc. left Corium, Inc.
- A Safety/Tolerability and PK Study With Azstarys® in Children With ADHDCompletedNCT05721235Phase 4
- Determine PK Profiles of Ozanimod and Its' Major Metabolites in Healthy SubjectsCompletedNCT06528665
Sponsor listed in the registry: Corium Innovations, Inc. · First submitted after Corium Innovations, Inc. left Corium, Inc.
- Determine the Bioavailability of Selegiline TDS 6mg/24 Hours vs EMSAM in Healthy SubjectsCompletedNCT06607744
Sponsor listed in the registry: Corium Innovations, Inc. · First submitted after Corium Innovations, Inc. left Corium, Inc.
- An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHDCompletedNCT05685732Phase 4
- Pharmacokinetic Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy VolunteersCompletedNCT04617782Phase 1
- A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery SystemCompletedNCT03397862Phase 1
- A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)CompletedNCT03438604Phase 1
- A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body LocationsCompletedNCT03432195Phase 1
- A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®CompletedNCT03259958Phase 1
- A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®CompletedNCT02968719Phase 1